COMMUNIQUÉS West-GlobeNewswire

Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
26/11/2025
MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an abstract was accepted [...]
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
26/11/2025
RADNOR, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities [...]
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26/11/2025
NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split
26/11/2025
Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY [...]
Beyond Air® Announces Transition of Chief Financial Officer
26/11/2025
Launched search for permanent successor GARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical [...]
Tangram Therapeutics soumet une demande d’essai clinique pour une étude de phase 1/2 du TGM-312, un nouveau candidat ARNi expérimental pour le traitement de la MASH
26/11/2025
La société prévoit de lancer la première étude chez l’homme début 2026, les premières données étant attendues au second semestre 2026 La soumission de la demande d’essai clinique (CTA) marque l’avancée de la plateforme [...]
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
27/11/2025
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and 2026 objectives. We exceeded our internal metrics across all [...]
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
27/11/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of [...]
Este Surgery Launches Advanced DHI Hair Transplant in Turkey
26/11/2025
Turkey Raises the Bar in Medical Tourism with Advanced DHI Hair Transplant Technology Istanbul, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Turkey's growing share of the global medical tourism market has led to significant [...]
Las Trampas Releases Inclusive Holiday Hosting Guide to Support Adults With Disabilities
26/11/2025
Las Trampas shares tips any host can use to create welcoming, accessible gatherings LAFAYETTE, CA , Nov. 26, 2025 (GLOBE NEWSWIRE) -- Las Trampas , a nonprofit organization supporting adults with intellectual and [...]
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
26/11/2025
COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will provide the state of business and give a recap of the [...]
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
26/11/2025
-- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, [...]
IO Biotech Announces Participation in Upcoming December Investor Conferences
26/11/2025
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the [...]
Valneva va consolider ses activités en France
26/11/2025
· Les activités françaises seront concentrées sur le site de Lyon · Consolidation de la R&D à Vienne Saint-Herblain (France), le 26 novembre 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a annoncé aujourd' [...]
Valneva to Further Consolidate its Operations in France
26/11/2025
French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna Saint- Herblain (France), November 26 , 202 5 –  Valneva SE  (Nasdaq: VALN; Euronext Paris: VLA) today announced a strategic [...]
All-on-Four Dental Implant Centers Announces Integration With Loocid’s Bone Cell Protection Technology, Reinforcing Role as Best All-on-4 Provider in New York & New Jersey
26/11/2025
New York and New Jersey’s best All-on-4 provider enhances surgical speed, precision, and bone preservation across all locations. New York, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- All-on-Four Dental Implant Centers , the [...]
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
26/11/2025
RAMAT GAN, Israel, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targeting oncological [...]
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
26/11/2025
MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the 8th [...]
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
26/11/2025
Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines. Exchange ratio of 0. [...]

Pages